Evidence map›Paper›PMID 32010038›Full record

ArticleFrontiers in neurology2019

Mutations of

Lulu Kang, Yi Liu, Ying Jin, Mengqiu Li, Jinqing Song, Yi Zhang, Yao Zhang, Yanling Yang

Open access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in neurology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. A clinical and genotype-phenotype analysis of MACF1 variants.American journal of human genetics · 2025
    Article
  4. Domain specific phenotypic expansion associated with variants inmedRxiv : the preprint server for health sciences · 2025
    Article
  5. A Multifaceted Giant Protein Microtubule-Actin Cross-Linking Factor 1.International journal of molecular sciences · 2025
    Review
  6. Review
  7. Review
  8. Article
  9. Strength Through Unity: The Power of the Mega-Scaffold MACF1.Frontiers in cell and developmental biology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Lulu KangDepartment of Pediatrics, Peking University First Hospital, Beijing, China.
Yi LiuDepartment of Pediatrics, Peking University First Hospital, Beijing, China.
Ying JinDepartment of Pediatrics, Peking University First Hospital, Beijing, China.
Mengqiu LiDepartment of Pediatrics, Peking University First Hospital, Beijing, China.
Jinqing SongDepartment of Pediatrics, Peking University First Hospital, Beijing, China.
Yi ZhangEuler Genomics, Beijing, China.
Yao ZhangDepartment of Pediatrics, Peking University First Hospital, Beijing, China.
Yanling YangDepartment of Pediatrics, Peking University First Hospital, Beijing, China.
Peking University First Hospital · CNPeking University · CNEuler Technology (China)

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As a member of spectraplakin family of cytoskeletal crosslinking proteins, microtubule-actin crosslinking factor 1 (MACF1) controls cytoskeleton network dynamics. Knockout of

Indexed as

MACF1myopathyneuromuscular disorderspectraplakinopathywhole exome sequencing

Identifiers

PMID32010038
PMCPMC6974614
OpenAlexW2993548113

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.